COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2249: Articles 22481-22490  | Next

Discovery and Development of Human SARS-CoV-2 Neutralizing Antibodies using an Unbiased Phage Display Library Approach
Cao, X., Maruyama, J., Zhou, H., Kerwin, L., Sattler, R., Manning, J. T., Johnson, S., Richards, S., Blair, B., Du, N., Morais, K., Lawrence, K., Lu, L., Pai, C.-I., Li, D., Brunswick, M., Zhang, Y., Ji, H., Paessler, S., Allen, R. D.
10.1101/2020.09.27.316174 — Posted: 2020-09-28
A Tethered Ligand Assay to Probe the SARS-CoV-2 ACE2 Interaction under Constant Force
Bauer, M. S., Gruber, S., Milles, L. F., Nicolaus, T., Schendel, L. C., Gaub, H. E., Lipfert, J.
10.1101/2020.09.27.315796 — Posted: 2020-09-28
Ultrafast Sample Placement on Existing Trees (UShER) Empowers Real-Time Phylogenetics for the SARS-CoV-2 Pandemic
Turakhia, Y., Thornlow, B., Hinrichs, A. S., de Maio, N., Gozashti, L., Lanfear, R., Haussler, D., Corbett-Detig, R.
10.1101/2020.09.26.314971 — Posted: 2020-09-28
No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease
Alquicira-Hernandez, J., Powell, J., Phan, T. G.
10.1101/2020.09.27.312538 — Posted: 2020-09-28 Discussion: Onsite
Identification of TMEM106B as proviral host factor for SARS-CoV-2
Baggen, J., Persoons, L., Jansen, S., Vanstreels, E., Jacquemyn, M., Jochmans, D., Neyts, J., Dallmeier, K., Maes, P., Daelemans, D.
10.1101/2020.09.28.316281 — Posted: 2020-09-28
Genome-Wide Asymptomatic B-Cell, CD4+ and CD8+ T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Immune Targets for Pre-Emptive Pan-Coronavirus Vaccines
Prakash, S., Ruchi, S., Coulon, P.-G., Dhanushkodi, N. R., Chentoufi, A. A., Tifrea, D. F., Edwards, R. A., Figueroa, C. J., Schubl, S. D., Hsieh, L., Buchmeier, M. J., Bouziane, M., Nesburn, A. B., Kuppermann, B. D., BenMohamed, L.
10.1101/2020.09.27.316018 — Posted: 2020-09-28
Strong impact of closing schools, closing bars and wearing masks during the Covid-19 pandemic: results from a simple and revealing analysis
Matzinger, P., Skinner, J.
10.1101/2020.09.26.20202457 — Posted: 2020-09-28
A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study
Linssen, J., Ermens, A., Berrevoets, M., Seghezzi, M., Previtali, G., van der Sar-van der Brugge, S., Russcher, H., Verbon, A., Gillis, J. M. E. P., Riedl, J., de Jongh, E., Saker, J., Munster, M., Munnix, I. C. A., Dofferhoff, A., Scharnhorst, V., Ammerlaan, H., Deiteren, K., Bakker, S. J. L., van Pelt, L. J., Kluiters-de Hingh, Y., Leers, M. P. G., van der Ven, A.
10.1101/2020.09.27.20202168 — Posted: 2020-09-28
Scrutinizing the Spread of Covid-19 in Madagascar
Narison, S., Maltezos, S.
10.1101/2020.09.27.20202556 — Posted: 2020-09-28
Remdesivir for the treatment of COVID-19: A living systematic review
Verdugo-Paiva, F., Acuna, M. P., Sola, I., Rada, G.
10.1101/2020.09.27.20202754 — Posted: 2020-09-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).